Business Law
Nov. 4, 2026
$17.5M shareholder dispute goes to trial over COVID test kit profits
Two former Pasaca Capital executives accuse founder Charles Huang of excluding them from lucrative shareholder buyouts while paying five other investors $100 per share. The defense says the plaintiffs contributed nothing to the company's COVID-19 testing windfall.
A $17.5 million shareholder dispute went to trial Tuesday in Los Angeles federal court, where two former executives of a Pasadena investment firm that made billions selling COVID-19 test kits to the British government accused its founder of excluding them from lucrative stock buyouts.
Darren Marino and Mark DePietro allege that Charles Chunhua Huang, founder and chairman of Pasaca Capital Inc., breached his fiduciary duties by authorizing approximately $100 million in payments to f...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In